{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:48:34Z","timestamp":1792169314144,"version":"4.4.0"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jns.2026.126221","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:09:05Z","timestamp":1791904145000},"page":"126221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comment on \u201cPlasma signatures of type 2 inflammation and vascular remodeling in moyamoya disease\u201d"],"prefix":"10.1016","volume":"491","author":[{"given":"Lingzhi","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2026.126221_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2026.126153","article-title":"Plasma signatures of type 2 inflammation and vascular remodeling in moyamoya disease","volume":"490","author":"Park","year":"2026","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.jns.2026.126221_bb0010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/intimm\/dxag011","article-title":"RNF213-TRAF2 interaction enhances inflammatory responses via NF-\u03baB activation in moyamoya disease","volume":"38","author":"Yasuda","year":"2026","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.jns.2026.126221_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/bio.2015.0059","article-title":"Impact of whole-blood processing conditions on plasma and serum concentrations of cytokines","volume":"14","author":"Lee","year":"2016","journal-title":"Biopreserv. Biobank."},{"key":"10.1016\/j.jns.2026.126221_bb0020","article-title":"Using the influenza vaccine as a mild, exogenous inflammatory challenge: when does inflammation peak?","volume":"13","author":"Radin","year":"2021","journal-title":"Brain Behav Immun Health"},{"issue":"9","key":"10.1016\/j.jns.2026.126221_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12091050","article-title":"A serum multi-parametric analysis identifies an early innate immune signature associated to increased vaccine-specific antibody production and seroconversion in simultaneous COVID-19 mRNA and cell-based quadrivalent influenza vaccination","volume":"12","author":"Severa","year":"2024","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.jns.2026.126221_bb0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.rinim.2011.07.002","article-title":"Increased IL-5 and IL-13 cytokine level in ex vivo stimulated whole blood cells from grass pollen allergic donors correlate with seasonal exposure","volume":"1","author":"Singh","year":"2011","journal-title":"Res. Immunol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26005034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26005034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:02:52Z","timestamp":1792166572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26005034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":6,"alternative-id":["S0022510X26005034"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.126221","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on \u201cPlasma signatures of type 2 inflammation and vascular remodeling in moyamoya disease\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.126221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126221"}}